Fibrinogen brescia -: Hepatic endoplasmic reticulum storage and hypofibrinogenemia because of a γ284 Gly→Arg mutation

被引:104
作者
Brennan, SO
Wyatt, J
Medicina, D
Callea, F
George, PM
机构
[1] Christchurch Hosp, Mol Pathol Lab, Christchurch, New Zealand
[2] Spedali Civili, Serv Anat Patol 1, I-25125 Brescia, Italy
关键词
D O I
10.1016/S0002-9440(10)64530-0
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The proposita suffered from liver cirrhosis and biopsy showed type 1 membrane-bound fiberglass inclusions. The hepatic Inclusion bodies were weakly periodic acid-Schiff diastase-positive, and on immunoperoxidase staining reacted specifically with anti-fibrinogen antisera, Coagulation investigations revealed low functional and antigenic fibrinogen together with a prolonged thrombin time of 37 seconds (normal, 17 to 22 seconds) suggestive of a hypodysfibrinogenemia. DNA sequencing of all three fibrinogen genes showed a single heterozygous mutation of GGG (Gly)->CGG (Arg) at codon 284 of the gamma-chain gene. However, examination of purified fibrinogen chains by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, reverse-phase high-performance liquid chromatography, ion-exchange high-performance liquid chromatography, and isoelectric focusing, failed to show any evidence of the mutant gamma(BR) chain in plasma fibrinogen. This finding was substantiated by electrospray ionization mass spectrometry, which showed only a normal gamma (and B beta) chain mass, but a large increase in the portion of their disialo isoforms, We speculate that misfolding of the variant protein causes hepatic retention and the subsequent hypofibrinogenemia, and that the functional defect (dysfibrinogenemia) results from hypersialylation of otherwise normal B beta and gamma chains consequent to the liver cirrhosis, These conclusions were supported by studies on six other family members with hypofibrinogenemia, and essentially normal clotting times, who were heterozygous for the gamma 284 Gly->Arg mutation.
引用
收藏
页码:189 / 196
页数:8
相关论文
共 30 条
[1]   HEREDITARY RENAL AMYLOIDOSIS ASSOCIATED WITH A MUTANT FIBRINOGEN ALPHA-CHAIN [J].
BENSON, MD ;
LIEPNIEKS, J ;
UEMICHI, T ;
WHEELER, G ;
CORREA, R .
NATURE GENETICS, 1993, 3 (03) :252-255
[2]   Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (A alpha 20 val->Asp) [J].
Brennan, SO ;
Hammonds, B ;
George, PM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (06) :2854-2858
[3]  
Brennan SO, 1998, THROMB HAEMOSTASIS, V80, P263
[4]  
Brennan SO, 1997, THROMB HAEMOSTASIS, V78, P1055
[5]  
BRENNAN SO, 1986, HEMOGLOBIN, V9, P53
[6]   FIBRINOGEN INCLUSIONS IN LIVER-CELLS - A NEW TYPE OF GROUND-GLASS HEPATOCYTE - IMMUNE LIGHT AND ELECTRON-MICROSCOPIC CHARACTERIZATION [J].
CALLEA, F ;
DEVOS, R ;
TOGNI, R ;
TARDANICO, R ;
VANSTAPEL, MJ ;
DESMET, VJ .
HISTOPATHOLOGY, 1986, 10 (01) :65-73
[7]  
CALLEA F, 1992, LIVER, V12, P357
[8]  
CALLEA F, 1987, FIBRINOGEN, V2, P75
[9]  
Carrell RW, 1996, BIOL CHEM H-S, V377, P1
[10]  
CARSON M, 1997, MACROMOLECULAR CRYST, P493